Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes

Takahiro Kogawa,Takeo Fujii,Tamer M. Fouad,Diane D Liu,Kenichi Harano,Hiroko Masuda,Toshiaki Iwase,Chad M. Barnett,Young Sam Park,Bora Lim,Debasish Tripathy,Jennifer Litton,Naoto T. Ueno

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes

2018

Takahiro Kogawa
Takeo Fujii
Tamer M. Fouad
Diane D Liu
Kenichi Harano
Hiroko Masuda
Toshiaki Iwase
Chad M. Barnett
Young Sam Park
Bora Lim
Debasish Tripathy
Jennifer Litton
Naoto T. Ueno

Purpose We hypothesized that an increase in BMI category during neoadjuvant chemotherapy (NAC) would be associated with pathological complete response (pCR) rate and worse survival outcomes in primary breast cancer patients.

Keywords:

Breast cancer
Cancer research
Body mass index
Chemotherapy
Medicine
Predictive marker
Internal medicine
Disease
Endocrinology
Oncology
Proportional hazards model
Pathological
Hazard ratio

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations